Changes

Line 67: Line 67:     
== Rearrangements ==
 
== Rearrangements ==
[[TERT]] (upstream) (5p15) (12%)
+
[[TERT]] (upstream) (5p15) (12%)<ref name=davis>Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA; Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>
    
== Mutations (SNV/INDEL) ==
 
== Mutations (SNV/INDEL) ==
   −
=== From Cosmic Mutated in >20% ===
+
=== From Cosmic Mutated in >20%<ref>COSMIC (http://cancer.sanger.ac.uk/cosmic)</ref> ===
 
=== Mutated in 10-20% ===
 
=== Mutated in 10-20% ===
 
[[TP53]]
 
[[TP53]]
Line 104: Line 104:     
==References==
 
==References==
1. Speicher MR, Schoell B, du Manoir S, Schröck E, Ried T, Cremer T, Störkel S,
  −
Kovacs A, Kovacs G.
  −
Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in
  −
chromophobe renal cell carcinomas revealed by comparative genomic hybridization.
  −
Am J Pathol. 1994 Aug;145(2):356-64.
  −
  −
2.  Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H,
  −
Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M,
  −
Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK,
  −
Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA; Cancer Genome
  −
Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson
  −
AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D,
  −
Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ.
  −
The somatic genomic
  −
landscape of chromophobe renal cell carcinoma.
  −
Cancer Cell. 2014 Sep 8;26(3):319-30.
  −
  −
3. Durinck S, Stawiski EW, Pavía-Jiménez A, Modrusan Z, Kapur P, Jaiswal BS,
  −
Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja KB, Chen YJ, Saleem S, Chaudhuri
  −
S, Heldens S, Jackson M, Peña-Llopis S, Guillory J, Toy K, Ha C, Harris CJ,
  −
Holloman E, Hill HM, Stinson J, Rivers CS, Janakiraman V, Wang W, Kinch LN,
  −
Grishin NV, Haverty PM, Chow B, Gehring JS, Reeder J, Pau G, Wu TD, Margulis V,
  −
Lotan Y, Sagalowsky A, Pedrosa I, de Sauvage FJ, Brugarolas J, Seshagiri S.
  −
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma
  −
subtypes. Nat Genet. 2015 Jan;47(1):13-21.
  −
  −
4. COSMIC (http://cancer.sanger.ac.uk/cosmic)